BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 24529325)

  • 1. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
    Trovato FM; Catalano D; Martines GF; Pace P; Trovato GM
    Clin Nutr; 2015 Feb; 34(1):86-8. PubMed ID: 24529325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
    Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
    Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography and NAFLD (non-alcoholic fatty liver disease).
    Trovato FM; Martines GF; Catalano D; Musumeci G; Pirri C; Trovato GM
    Int J Cardiol; 2016 Oct; 221():275-9. PubMed ID: 27404689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
    Mascaró CM; Bouzas C; Tur JA
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
    Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
    J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.
    Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Garozzo A; Castro A; Catalano D
    Dig Dis Sci; 2012 Feb; 57(2):535-44. PubMed ID: 21953137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
    Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
    Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol.
    Papamiltiadous ES; Roberts SK; Nicoll AJ; Ryan MC; Itsiopoulos C; Salim A; Tierney AC
    BMC Gastroenterol; 2016 Feb; 16():14. PubMed ID: 26831892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.
    Misciagna G; Del Pilar Díaz M; Caramia DV; Bonfiglio C; Franco I; Noviello MR; Chiloiro M; Abbrescia DI; Mirizzi A; Tanzi M; Caruso MG; Correale M; Reddavide R; Inguaggiato R; Cisternino AM; Osella AR
    J Nutr Health Aging; 2017; 21(4):404-412. PubMed ID: 28346567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Baratta F; Pastori D; Polimeni L; Bucci T; Ceci F; Calabrese C; Ernesti I; Pannitteri G; Violi F; Angelico F; Del Ben M
    Am J Gastroenterol; 2017 Dec; 112(12):1832-1839. PubMed ID: 29063908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
    Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA
    Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
    Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
    Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
    Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.